This review concluded that investigation of rectal bleeding or anaemia in primary patients was warranted irrespective of other symptoms. These conclusions should be interpreted with caution due to possible bias and errors in the review process, limitations in the analysis and heterogeneity across studies.
Authors' objectives
To determine the diagnostic value of symptoms associated with colorectal cancer.
Searching
MEDLINE, EMBASE, The Cochrane Library and CINAHL were searched to February 2010. There were no language restrictions. Search terms were reported and included a diagnostic filter. Ongoing studies were identified by searching relevant cancer websites. Reference lists of included studies were screened and authors were contacted.
Study selection
Studies of at least 100 primary care patients that evaluated the accuracy of symptoms (index test) for diagnosis of adenocarcinoma of the colon or rectum (target condition) against a reference standard of histology, colonoscopy, double-contrast barium enema, computerised tomography (CT) colonography or at least one years' clinical follow-up were eligible for inclusion. Studies of asymptomatic patients, patients already referred to secondary care and patients with recurrent colorectal cancer were excluded.
Most studies were conducted in Europe; single studies were in USA and Australia. Most studies were multicentre (only three were single-centre). Where reported, symptom data were collected using a questionnaire or template for patients or doctors, routine general practitioner (GP) processes/records or retrieved from NHS databases. Prevalence of colorectal cancer ranged from 0.4% to 23.2%; most studies reported a prevalence of 10% or less.
One reviewer screened the results of the searches for relevance; a second reviewer checked those identified as potentially relevant. It was unclear how full-text studies were assessed for inclusion.
Assessment of study quality
One reviewer assessed study quality using the 14-item QUADAS tool. Items for blinding of the reference standard and availability of clinical information to the person interpreting the index test were removed. An item on description of symptoms was added to the tool.
Data extraction
One reviewer extracted data to populate 2x2 tables of test performance and a second reviewer checked. Data were used to calculate sensitivity specificity, positive and negative likelihood ratios and positive predictive values and likelihood ratios.
Methods of synthesis
Summary sensitivity, specificity and positive and negative likelihood ratios were calculated together with 95% confidence intervals (CIs). Summary positive predictive values were calculated for symptoms evaluated in cohort studies. Heterogeneity was assessed using I 2 and X 2 . Subgroup analysis was conducted to investigate the influence of age, sample size, single centre versus multicentre, study design, data collection by template or questionnaire versus consultation, quality criteria and studies of first-onset only rectal bleeding versus all times of onset.
